CHEEVER CHARLIE E III purchased $115K of CVSI

CHEEVER CHARLIE E III purchased 5,740,816 shares of CV Sciences, Inc. (CVSI) at $0.02 ($0.11M total) across 10 trades over 2026-07-16 to 2026-08-07.

Original reporting
SEC EDGAR · CHEEVER CHARLIE E III
Published Sep 9, 2026, 10:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 10:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CVSI
Bullish
medium confidence
Mentioned
$CVSI
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CVSIBullishLow
01

Why it matters

The purchase adds to the insider's stake, possibly indicating confidence, but the monetary size is small relative to market cap.

02

Market read

Primary insider purchase filing; modest relevance for traders monitoring micro‑cap insider activity.

03

What to watch

Potential upcoming clinical data releases or financing events not disclosed in the filing.

Relevance 5/10Novelty 5/10Timing: Filed Sep 9 2026

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources of new information.

Company-level read

Ticker impact

$CVSIBullishMedium confidence
Context

Insider CHEEVER CHARLIE E III bought 5,740,816 shares for $114,816, raising holdings to 26,648,711 shares.

Expected impact

Potential modest price lift in the next few trading sessions.

Evidence & confidence

The purchase size is notable for a micro‑cap, but the total dollar amount is modest; market reaction may be limited.

Market effects

Minimal impact on the broader biotech sector; insider activity is company‑specific.

No regional effect; the filing is U.S. SEC‑based.

Limited global relevance; only investors in CVSI may react.

Counterpoint

Insider buying could be a routine portfolio rebalancing rather than a bullish signal.

Key entities

  • CV Sciences, Inc.

    Biotech firm listed on NASDAQ under CVSI.

  • CHEEVER CHARLIE E III

    10% owner of CVSI.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CVSIMed

CV Sciences, Inc. Reports Third Quarter-End 2026 Financial Results

CV Sciences, Inc. (CVSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CV Sciences, Inc. Reports Third Quarter-End 2026 Financial Results San Diego, CA - November 12, 2026 (ACCESS Newswire) - CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp ex

$CVSIMed

CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results

CV Sciences, Inc. (CVSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results San Diego, CA - August 13, 2026 (ACCESS Newswire) - CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp ext